| Symbol | BAYRY |
|---|---|
| Name | BAYER A.G. |
| Sector | UNDEFINED |
| Region | Europe |
| Industry | - |
| Address | 51368 Germany Bayer AG Building W11 Kaiser-Wilhelm-Allee |
| Telephone | +49 214 30 72704 |
| Fax | — |
| — | |
| Website | http://www.bayer.com |
| Incorporation | DE |
| Incorporated On | 1863 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Deloitte GmbH - Germany; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Frankfurt Stock Exchange |
| CIK | 0001144145 |
| Description | Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, "Health for all, Hunger for none," the companys products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of 46.6 billion euros. R&D expenses amounted to 6.2 billion euros. For more information, go to www.bayer.com. Additional info from OTC: |
New Study Highlights Societal Optimism Toward Breakthrough Science, and Rising Anxiety About How Fast the World Is Changing
Read more